Wednesday, September 28, 2016

Citracal Maximum + D


Generic Name: calcium and vitamin D combination (KAL see um and VYE ta min D)

Brand Names: Calcarb with D, Calcet, Calcio Del Mar, Calcitrate with D, Calcium 600+D, Caltrate 600 with D, Caltrate 600 with D Plus Soy, Caltrate Colon Health, Citracal + D, Citracal 250 mg + D, Citracal Creamy Bites, Citracal Maximum + D, Citracal Petites, Citrus Calcium with Vitamin D, Dical-D, Os-Cal 250 with D, Os-Cal 500 + D, Os-Cal with D, Oysco 500 with D, Oysco D, Oyst-Cal-D, Oyster Shell Calcium with Vitamin D, Oyster-D, Oystercal-D, Posture-D H/P, Risacal-D


What is Citracal Maximum + D (calcium and vitamin D combination)?

Calcium is a mineral that is found naturally in foods. Calcium is necessary for many normal functions of your body, especially bone formation and maintenance.


Vitamin D is important for the absorption of calcium from the stomach and for the functioning of calcium in the body.


Calcium and vitamin D combination is used to prevent or to treat a calcium deficiency.


Calcium and vitamin D combination may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Citracal Maximum + D (calcium and vitamin D combination)?


Before you take calcium and vitamin D combination, tell your doctor if you have kidney disease, past or present kidney stones, heart disease, circulation problems, a parathyroid disorder, or if you are pregnant or breast-feeding.


Avoid taking any other vitamin or mineral supplements that contain calcium or vitamin D without first talking to your doctor.

Before taking calcium and vitamin D combination, tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.


What should I tell my healthcare provider before taking Citracal Maximum + D (calcium and vitamin D combination)?


If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before you take calcium and vitamin D combination, tell your doctor if you have:


  • kidney disease;

  • past or present kidney stones;


  • heart disease;




  • circulation problems; or




  • a parathyroid gland disorder.




Talk to your doctor before taking calcium and vitamin D combination if you are pregnant. Talk to your doctor before taking calcium and vitamin D combination if you are breast-feeding.

How should I take Citracal Maximum + D (calcium and vitamin D combination)?


Take this medication exactly as prescribed by your doctor. Do not take it in larger amounts or for longer than recommended. Follow the directions on your prescription label.


Take the calcium and vitamin D regular tablet with a full glass of water.

The chewable tablet should be chewed before you swallow it.


Store calcium and vitamin D combination at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include irregular heartbeat, stomach pain, nausea, vomiting, dry mouth, a metallic taste in your mouth, confusion, loss of appetite, constipation, weakness, headache, confusion, or fainting.


What should I avoid while taking Citracal Maximum + D (calcium and vitamin D combination)?


Avoid taking any other vitamin or mineral supplements that contain calcium or vitamin D without first talking to your doctor.

Citracal Maximum + D (calcium and vitamin D combination) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Less serious side effects may include:



  • an irregular heartbeat;




  • nausea, vomiting, or decreased appetite;




  • dry mouth;




  • constipation;




  • weakness;




  • headache;




  • a metallic taste;




  • muscle or bone pain; or




  • drowsiness.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Citracal Maximum + D (calcium and vitamin D combination)?


Before taking calcium and vitamin D combination, tell your doctor if you are taking:



  • digoxin (Lanoxin, Lanoxicaps);




  • antacids containing calcium, aluminum, or magnesium;




  • other calcium supplements;




  • calcitriol (Rocaltrol) or other vitamin D supplements; or




  • a tetracycline antibiotic such as demeclocycline (Declomycin), doxycycline (Adoxa, Doryx, Oracea, Vibramycin), minocycline (Dynacin, Minocin, Solodyn, Vectrin), or tetracycline (Brodspec, Panmycin, Sumycin, Tetracap).



This list is not complete and there may be other drugs that can interact with calcium and vitamin D combination. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Citracal Maximum + D resources


  • Citracal Maximum + D Side Effects (in more detail)
  • Citracal Maximum + D Use in Pregnancy & Breastfeeding
  • Citracal Maximum + D Drug Interactions
  • Citracal Maximum + D Support Group
  • 0 Reviews for Citracal Maximum + D - Add your own review/rating


Compare Citracal Maximum + D with other medications


  • Dietary Supplementation
  • Osteoporosis


Where can I get more information?


  • Your pharmacist can provide more information about calcium and vitamin D combination.

See also: Citracal Maximum + D side effects (in more detail)


ciprofloxacin otic



Generic Name: ciprofloxacin otic (SIP roe FLOX a sin OH tik)

Brand Names: Cetraxal


What is ciprofloxacin otic?

Ciprofloxacin es an antibiotic that fights bacteria.


Ciprofloxacin otic (for the ears) is used to treat ear infections that affect the outer ear canal. This type of ear infection is sometimes called "swimmer's ear."


Ciprofloxacin otic may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about ciprofloxacin otic?


You should not use this medication if you are allergic to ciprofloxacin (Cipro). Avoid getting this medication in your mouth or eyes or on the skin. If it does get into any of these areas, rinse with water. Stop using this medication and call your doctor at once if you have any skin rash (no matter how mild), white patches in your mouth or throat, or vaginal itching or discharge.

Use this medication for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Call your doctor if your infection does not improve after using ciprofloxacin otic, or if your symptoms get worse.


What should I discuss with my health care provider before using ciprofloxacin otic?


You should not use this medication if you are allergic to ciprofloxacin (Cipro). FDA pregnancy category C. It is not known whether ciprofloxacin otic ear drops are harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether ciprofloxacin otic passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use ciprofloxacin otic?


Use this medication exactly as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended. Follow the directions on your prescription label.


Otic medications are for use only the ear. Do not take ciprofloxacin otic by mouth or apply it to the skin. Wash your hands before using this medication.

Ciprofloxacin otic comes in single-use containers. Each container has enough medicine in it for one dose.


Before using the medication, warm the container by holding it in your hands for at least a minute. Using ciprofloxacin otic that is cold may cause dizziness when you place the medicine into your ear.

To use the ear drops, lie down with your ear facing upward. Pull back on your ear gently to open up the ear canal. If giving this medicine to a child, pull down on the earlobe to open the ear canal. Empty all of the medicine from the container into the ear and stay lying down for at least 1 minute longer.


If you are treating both ears, repeat the instructions above using a second container of ciprofloxacin otic.


Ciprofloxacin should be used 2 times daily for 7 days, unless your doctor tells you otherwise. Your doses should be spaced at least 12 hours apart.


Each single-use container of this medicine is for one use only. Throw away the container after one use, even if there is still some medicine left in it.


Use this medication for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Call your doctor if your infection does not improve after using ciprofloxacin otic, or if your symptoms get worse.


Store this medication at room temperature away from moisture, heat, and light. Keep each single-use container in the foil pouch until you are ready to use the medication.

What happens if I miss a dose?


Use the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to use the medicine and skip the missed dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

An overdose of ciprofloxacin otic is not likely to cause life-threatening symptoms.


What should I avoid while using ciprofloxacin otic?


Avoid getting this medication in your mouth or eyes or on the skin. If it does get into any of these areas, rinse with water.

Ciprofloxacin otic side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have a serious side effect such as:

  • the first sign of any skin rash, no matter how mild;




  • white patches in your mouth or throat; or




  • vaginal itching or discharge.



Less serious side effects may include:



  • headache; or




  • itching, pain, or mild irritation after using the ear drops.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Ciprofloxacin otic Dosing Information


Usual Adult Dose for Acute Otitis Externa:

Contents of one single use container should be instilled into the affected ear twice daily (approximately 12 hours apart) for 7 days.
(ciprofloxacin 0.5 mg in 0.25 mL in each single use container).

Usual Pediatric Dose for Acute Otitis Externa:

1 year or older:
Contents of one single use container should be instilled into the affected ear twice daily (approximately 12 hours apart) for 7 days.
(ciprofloxacin 0.5 mg in 0.25 mL in each single use container).


What other drugs will affect ciprofloxacin otic?


It is not likely that other drugs you take orally or inject will have an effect on ciprofloxacin otic used in the ears. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More ciprofloxacin otic resources


  • Ciprofloxacin otic Dosage
  • Ciprofloxacin otic Use in Pregnancy & Breastfeeding
  • Ciprofloxacin otic Support Group
  • 0 Reviews for Ciprofloxacin - Add your own review/rating


  • Cetraxal Prescribing Information (FDA)

  • Cetraxal Advanced Consumer (Micromedex) - Includes Dosage Information

  • Cetraxal Ear Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Cetraxal Consumer Overview



Compare ciprofloxacin otic with other medications


  • Acute Otitis Externa


Where can I get more information?


  • Your pharmacist can provide more information about ciprofloxacin otic.


Tuesday, September 27, 2016

Mepivacaina




Mepivacaina may be available in the countries listed below.


Ingredient matches for Mepivacaina



Mepivacaine

Mepivacaina (DCIT) is known as Mepivacaine in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Entereg


Entereg is a brand name of alvimopan, approved by the FDA in the following formulation(s):


ENTEREG (alvimopan - capsule; oral)



  • Manufacturer: ADOLOR

    Approval date: May 20, 2008

    Strength(s): 12MG [RLD]

Has a generic version of Entereg been approved?


No. There is currently no therapeutically equivalent version of Entereg available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Entereg. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Peripherally selective piperidine carboxylate opioid antagonists
    Patent 5,250,542
    Issued: October 5, 1993
    Inventor(s): Cantrell; Buddy E. & Zimmerman; Dennis M.
    Assignee(s): Eli Lilly and Company
    3,4,4-trisubstitutedpiperidinyl-N-alkylcarboxylates and intermediates for their preparation are provided. These piperidine-N-alkylcarboxylates are useful as peripheral opioid antagonists.
    Patent expiration dates:

    • March 29, 2016
      ✓ 
      Patent use: A METHOD FOR BINDING A PERIPHERAL OPIOID RECEPTOR
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates
    Patent 5,434,171
    Issued: July 18, 1995
    Inventor(s): Frank; Scott A. & Prather; Douglas E. & Ward; Jeffrey A. & Werner; John A.
    Assignee(s): Eli Lilly and Company
    This invention relates to a process for preparing certain 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates, intermediates, and congeners. Finally, the invention provides new 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates with formulations and methods for using the compounds.
    Patent expiration dates:

    • December 8, 2013
      ✓ 
      Patent use: A METHOD FOR BINDING A PERIPHERAL OPIOID RECEPTOR
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Methods for the treatment and prevention of ileus
    Patent 6,469,030
    Issued: October 22, 2002
    Inventor(s): John J.; Farrar & Peter J.; Schied & William K.; Schmidt & Randall L.; Carpenter
    Assignee(s): Adolor Corporation
    Methods for the treatment and/or prevention of ileus are disclosed. The methods comprise administering to a patient an effective amount of a peripheral mu opioid antagonist compound. Preferred compounds for use in the methods include piperidine-N-alkylcarboxylates.
    Patent expiration dates:

    • November 29, 2020
      ✓ 
      Patent use: A METHOD OF TREATING OR PREVENTING ILEUS



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • May 20, 2013 - NEW CHEMICAL ENTITY

See also...

  • Entereg Consumer Information (Drugs.com)
  • Entereg Consumer Information (Wolters Kluwer)
  • Entereg Consumer Information (Cerner Multum)
  • Entereg Advanced Consumer Information (Micromedex)
  • Entereg AHFS DI Monographs (ASHP)
  • Alvimopan Consumer Information (Wolters Kluwer)
  • Alvimopan Consumer Information (Cerner Multum)
  • Alvimopan Advanced Consumer Information (Micromedex)
  • Alvimopan AHFS DI Monographs (ASHP)

Voltarol Ophtha




Voltarol Ophtha may be available in the countries listed below.


Ingredient matches for Voltarol Ophtha



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Voltarol Ophtha in the following countries:


  • Ireland

  • New Zealand

International Drug Name Search

Ninazo




Ninazo may be available in the countries listed below.


Ingredient matches for Ninazo



Naphazoline

Naphazoline nitrate (a derivative of Naphazoline) is reported as an ingredient of Ninazo in the following countries:


  • Venezuela

International Drug Name Search

TopiLEK




TopiLEK may be available in the countries listed below.


Ingredient matches for TopiLEK



Topiramate

Topiramate is reported as an ingredient of TopiLEK in the following countries:


  • Poland

International Drug Name Search